Advertisement

Topics

Chroma Therapies Company Profile

18:48 EDT 18th August 2018 | BioPortfolio


News Articles [223 Associated News Articles listed on BioPortfolio]

Chroma Therapeutics’ Deal with GlaxoSmithKline

At the BIA Leadership Summit, Dr Fintan Walton spoke to Ian Nicholson, CEO of Chroma Therapeutics. They discussed: • Chroma’s deal with GSK • the key to Chroma’s novel chemistry platform tech...

Ian Nicholson of Chroma Therapeutics discusses their recent deal with CTI

In this episode of PharmaTelevision News Review, Fintan Walton talks to Ian Nicholson, CEO at Chroma Therapeutics

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

Opportunity remains in oncology for gene therapies, says GlobalData

Small pharma leads the way in cancer gene therapies Gene therapies combine reduced treatment duration with a higher chance of...Read More... The post Opportunity remains in oncology for gene therapies...

Gene Therapies are Proving their Worth, but with Million Dollar Price Tags, it’s not Clear Who should Pay for Them

Sterghios Moschos, Associate Professor in Cellular and Molecular Sciences at Northumbria University discusses the benefits of gene therapies and the financial implications of treatments. If you were b...

In a bid to promote stem cell therapies, health officials open a new door for promising contenders

At a time when there’s significant hype around stem cell therapies, the FDA is moving to promote therapies that show the greatest potential.

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

FDA Sets Path for Stem Cell Therapies

(CNN) – Just months after the US Food and Drug Administration announced efforts to crack down on stem cell clinics touting unapproved therapies, the agency now plans to help expedite the develop...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Hepsera [Excella GmbH]

These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA. HEPSERA (adefovir dipivoxil) tablet for oral use Initia...

Hepsera [Gilead Sciences, Inc.]

These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA. HEPSERA (adefovir dipivoxil) tablet for oral use Initia...

Olay total effects uv moisturizer [Procter & Gamble Manufacturing Company]

OLAY total effects

PubMed Articles [531 Associated PubMed Articles listed on BioPortfolio]

Efficacy of Pain Relief in Different Postherpetic Neuralgia Therapies: A Network Meta-Analysis.

Postherpetic neuralgia (PHN) is a nerve pain disease usually controlled by different therapies, i.e., topical therapies, antiepileptics, analgesics, antipsychotics, antidepressants, anti-dementia drug...

Emerging therapies for mitochondrial diseases.

For the vast majority of patients with mitochondrial diseases, only supportive and symptomatic therapies are available. However, in the last decade, due to extraordinary advances in defining the cause...

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies.

The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: A systematic review and best-evidence synthesis.

Acne vulgaris is a multifaceted skin disorder, affecting more than 85% of young individuals worldwide. Pharmacological therapy is not always desirable because of the development of antibiotic resistan...

Cardiac resynchronization therapy is associated with a reduction in ICD therapies, while improves ventricular function.

Repeated implantable cardioverter-defibrillator (ICD) therapies cause myocardial damage and thus, an increased risk of arrhythmias and mortality.

Clinical Trials [1569 Associated Clinical Trials listed on BioPortfolio]

Randomized Clinical Trial of Occlusal Sealant

This study assessed long-term impact of tooth Eruption Stages (ES) on sealant retention on occlusal surfaces previously coated with intermediary bonding layer and it determined caries inci...

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

The purpose of this study is to observe and describe treatment patterns, like Overactive Bladder (OAB) treatment discontinuation, switching to other therapies and persistence of OAB therap...

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA)

This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injection...

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Companies [853 Associated Companies listed on BioPortfolio]

Chroma Therapies

Chroma Technology Corp

Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pa...

Chroma Therapeutics Ltd

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology. Chroma is the first company to system...

Chroma Technology Corp.

Toler RX Incorporated

TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...

More Information about "Chroma Therapies" on BioPortfolio

We have published hundreds of Chroma Therapies news stories on BioPortfolio along with dozens of Chroma Therapies Clinical Trials and PubMed Articles about Chroma Therapies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chroma Therapies Companies in our database. You can also find out about relevant Chroma Therapies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record